glp-1 and intermittent fasting GLP-1: combining fasting with weight loss medications Fasting with GLP-1: Safe Intermittent

GRAPPA 2013 annual meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Recent labs are strongly recommended (but not required) prior to initiation of most weight loss medications

Patients and plaintiffs lawyers argue that Novo Nordisk failed to warn prescribing physicians and patients about the risks of delayed gastric emptying and other serious side effects

Discover how GLP-1 medications may support your wellness goals